Haruno A - Search Results

1

Effect of coadministration of uracil on the toxicity of tegafur.

Yamamoto J, Haruno A, Yoshimura Y, Unemi N, Kunimune Y, Yamashita K, Morita K. Yamamoto J, et al. Among authors: haruno a. J Pharm Sci. 1984 Feb;73(2):212-4. doi: 10.1002/jps.2600730217. J Pharm Sci. 1984. PMID: 6423805

2

General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.

Yamamoto J, Toide K, Haruno A, Yoshimura Y, Unemi N. Yamamoto J, et al. Among authors: haruno a. Arzneimittelforschung. 1981;31(8):1268-78. Arzneimittelforschung. 1981. PMID: 6794578

3

Effects of propiverine hydrochloride on the spontaneous contractions of isolated guinea-pig urinary bladder strip and rhythmic urinary bladder contractions of anesthetized dog.

Haruno A. Haruno A. Arzneimittelforschung. 1992 Dec;42(12):1459-61. Arzneimittelforschung. 1992. PMID: 1288511

4

Inhibitory effects of propiverine hydrochloride on the agonist-induced or spontaneous contractions of various isolated muscle preparations.

Haruno A. Haruno A. Arzneimittelforschung. 1992 Jun;42(6):815-7. Arzneimittelforschung. 1992. PMID: 1418036

5

[Effects of propiverine hydrochloride and its metabolites on isolated guinea pig urinary bladder].

Haruno A, Yamasaki Y, Miyoshi K, Miyake H, Tsuchiya K, Kosaka M, Nagai M, Iriki M. Haruno A, et al. Nihon Yakurigaku Zasshi. 1989 Aug;94(2):145-50. doi: 10.1254/fpj.94.145. Nihon Yakurigaku Zasshi. 1989. PMID: 2807071 Japanese.

6

[Effect of propiverine hydrochloride on the function of the bladder in dogs].

Kaneko S, Haruno A, Suzuki N, Kitazato K, Yamazaki Y, Nagai M, Iriki M, Tsuchiya K, Kosaka M. Kaneko S, et al. Among authors: haruno a. Nihon Yakurigaku Zasshi. 1989 Feb;93(2):55-60. Nihon Yakurigaku Zasshi. 1989. PMID: 2722084 Japanese.

7

Pharmacological profile of TH-142177, a novel orally active AT1-receptor antagonist.

Nozawa Y, Haruno A, Oda N, Yamasaki Y, Matsuura N, Miyake H, Yamada S, Kimura R. Nozawa Y, et al. Among authors: haruno a. Fundam Clin Pharmacol. 1997;11(5):395-401. doi: 10.1111/j.1472-8206.1997.tb00201.x. Fundam Clin Pharmacol. 1997. PMID: 9342592

8

Cardiovascular profile of MPC-1304, a novel dihydropyridine calcium antagonist: comparison with other calcium antagonists.

Kanda A, Haruno A, Miyoshi K, Tanahashi Y, Miyake H, Ichihara K, Okumura K, Nagasaka M. Kanda A, et al. Among authors: haruno a. J Cardiovasc Pharmacol. 1993 Jul;22(1):167-75. doi: 10.1097/00005344-199307000-00025. J Cardiovasc Pharmacol. 1993. PMID: 7690090

9

Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.

Kanda A, Haruno A, Miyake H, Nagasaka M. Kanda A, et al. Among authors: haruno a. J Cardiovasc Pharmacol. 1992;20(5):723-30. J Cardiovasc Pharmacol. 1992. PMID: 1280733

10

Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.

Matsuzaki T, Haruno A, Hashimoto K. Matsuzaki T, et al. Among authors: haruno a. Eur J Pharmacol. 1993 Feb 16;231(3):363-70. doi: 10.1016/0014-2999(93)90111-t. Eur J Pharmacol. 1993. PMID: 8449229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters